These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2921218)

  • 1. Microbial O-phosphorylation of macrolide antibiotics.
    Marshall VP; Cialdella JI; Baczynskyj L; Liggett WF; Johnson RA
    J Antibiot (Tokyo); 1989 Jan; 42(1):132-4. PubMed ID: 2921218
    [No Abstract]   [Full Text] [Related]  

  • 2. Decrease in accumulation of macrolide antibiotics as a mechanism of resistance in Staphylococcus aureus.
    Yamagishi S; Nakajima Y; Inoue M; Oka Y
    Jpn J Microbiol; 1971 Jan; 15(1):39-52. PubMed ID: 5313613
    [No Abstract]   [Full Text] [Related]  

  • 3. Enzymatic phosphorylation of macrolide antibiotics.
    Wiley PF; Baczynskyj L; Dolak LA; Cialdella JI; Marshall VP
    J Antibiot (Tokyo); 1987 Feb; 40(2):195-201. PubMed ID: 3570968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research on the residues of two antibiotics of the macrolide group (oleandomycin and spiramycin) in the tissues of chickens receiving antibiotic-supplemented feed].
    Pilet C; Toma B
    Ann Nutr Aliment; 1968; 22(4):239-47. PubMed ID: 5681864
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug resistance to staphylococci. 3. Resistance to some macrolide antibiotics and inducible system.
    Kono M; Hashimoto H; Mitsuhashi S
    Jpn J Microbiol; 1966 Apr; 10(1):59-66. PubMed ID: 5297542
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the antibiotics from Streptomyces spinichromogenes var. kujimyceticus. V. Some antimicrobial characteristics of kujimycin A and kujimycin B against macrolide resistant staphylococci.
    Omura S; Namiki S; Shibata M; Muro T; Sawada J
    J Antibiot (Tokyo); 1970 Sep; 23(9):448-60. PubMed ID: 5202114
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimycoplasma activities of macrolide antibiotics.
    Omura S; Hironaka Y; Nakagawa A; Umezawa I; Hata T
    J Antibiot (Tokyo); 1972 Feb; 25(2):105-8. PubMed ID: 5034806
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug resistance of staphylococci. IX. Inducible resistance to macrolide antibiotics in Staphylococcus aureus.
    Hashimoto H; Oshima H; Mitsuhashi S
    Jpn J Microbiol; 1968 Sep; 12(3):321-7. PubMed ID: 4236812
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of glycosylation and deglycosylation in biosynthesis of and resistance to oleandomycin in the producer organism, Streptomyces antibioticus.
    Vilches C; Hernandez C; Mendez C; Salas JA
    J Bacteriol; 1992 Jan; 174(1):161-5. PubMed ID: 1530845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The affinity for monkey tissue of five antibiotics having erythromycin-like spectra.
    EIDUS L; MANIAR AC; FU RESZ J
    Chemotherapia (Basel); 1962; 4():398-404. PubMed ID: 13889602
    [No Abstract]   [Full Text] [Related]  

  • 11. Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics.
    Niitu Y; Hasegawa S; Suetake T; Kubota H; Komatsu S; Horikawa M
    J Pediatr; 1970 Mar; 76(3):438-43. PubMed ID: 5413664
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibacterial activity of megalomicin and its inducer activity for macrolide resistance in Staphylococci.
    Saito T; Mitsuhashi S
    J Antibiot (Tokyo); 1971 Dec; 24(12):850-4. PubMed ID: 5140532
    [No Abstract]   [Full Text] [Related]  

  • 13. The microbial transformation of tylosin by the spiramycin-producing strain, Streptomyces ambofaciens KA-1028.
    Omura S; Kitao C; Sadakane N
    J Antibiot (Tokyo); 1980 Aug; 33(8):911-2. PubMed ID: 7429995
    [No Abstract]   [Full Text] [Related]  

  • 14. [Future development of antibiotics. 5. Macrolide antibiotics].
    Inoue M
    Nihon Rinsho; 1984 Mar; 42(3):553-9. PubMed ID: 6381795
    [No Abstract]   [Full Text] [Related]  

  • 15. Interspecies correlation of the pharmacokinetics of erythromycin, oleandomycin, and tylosin.
    Duthu GS
    J Pharm Sci; 1985 Sep; 74(9):943-6. PubMed ID: 4067847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oleandomycin content of mycelium and fermentation solution during cultivation of Streptomyces antibioticus].
    Shukoliukov SA; Sokolova IB
    Antibiotiki; 1984 Dec; 29(12):892-7. PubMed ID: 6395796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation in vitro of the antibacterial activity of some antibiotics and chemotherapeutic agents on germs in sputum. V. Spiramycin, erythromycin and oleandomycin plus tetracycline].
    Russo R; De Vanna F; Carrozzo M; Pipitone V
    Boll Soc Ital Biol Sper; 1965 Sep; 41(18):1060-2. PubMed ID: 5878959
    [No Abstract]   [Full Text] [Related]  

  • 18. Deltamycins, new macrolide antibiotics. I. Producing organism and fermentation.
    Shimauchi Y; Okamura K; Koki A; Hasegawa M; Date M; Fukagawa Y; Kouno K; Ishikura T
    J Antibiot (Tokyo); 1978 Apr; 31(4):261-9. PubMed ID: 659323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mode of action of the protein, SP127, which enhances the activity of macrolide antibiotics against Pseudomonas aeruginosa.
    Kikuchi M; Nakao Y
    J Antibiot (Tokyo); 1977 Mar; 30(3):215-20. PubMed ID: 405356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of tetracyclines, macrolide antibiotics, and sigmamycin on staphylococci in vitro].
    Betinová M
    Biologia (Bratisl); 1968; 23(9):675-82. PubMed ID: 4971503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.